navicixizumab
·Code: OMP-305B83
navicixizumab: developed by 2 companies. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Mereo BioPharma Group plc (MREO) | Phase 1 |
| OncoMed Pharmaceuticals Inc (OMED) | Phase 2 |
Get deeper analysis on navicixizumab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis